Avicanna
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
480 University Ave Ste 1502, Toronto, On...Phone Number
(647) 243-5283Website
www.avicanna.comRevenue
$11.8 MillionStock Symbol
AVCN.TOIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Avicanna
Avicanna is an innovative biopharmaceutical company specializing in the development and commercialization of cannabinoid-based products for the medical and pharmaceutical markets. With a robust scientific platform, the company has successfully launched over thirty proprietary, evidence-based products and operates four commercial business pillars. Avicanna is dedicated to advancing the understanding and application of medical cannabis through extensive research and collaborations with leading academic and clinical institutions. The company aims to address global opportunities in the medical cannabis sector, leveraging its established infrastructure and intellectual property portfolio.Explore more
Avicanna Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Avicanna your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Avicanna has new funding data
Avicanna, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Avicanna is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Avicanna launches new products
Congratulate Masked Content for being promoted to Masked Content at Avicanna
Earning: See what the market has to say on Avicanna recently announced quarterly report
Click to see if Avicanna had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Avicanna has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Avicanna as Masked Content
Find 3 more new buyers
Compare Similar Companies to Avicanna
Compare insights from companies similar to Avicanna, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Avicanna is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Avicanna is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Avicanna.
Avicanna financials insights
Gather financial insights about Avicanna, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Angel/Seed
$1.2M
2018
Share Placement
$4.8M
2020
Share Placement
$2M
Debt
$1.1M
2021
Share Placement
$4.4M
Debt
$2.1M
Avicanna Tech Stack
A closer look at the technologies used by Avicanna
See more technologies
Most Recent Scoops
Lateral Move
Executive Move
Executive Moves, Lateral Move
Promotion
Executive Move
Executive Moves, Promotion
Project
Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Project
Product Management, Intellectual Property
Avicanna News & Media
Avicanna Inc. (AVCN:CA) Shareholder/Analyst Call Prepared Remarks Transcript
Avicanna Inc. (AVCN:CA) Shareholder/Analyst Call May 7, 2026 11:30 AM EDTCompany ParticipantsStephen Kim - Chief Legal Officer, General Counsel &...Avicanna Announces Results of Annual General and Special Meeting
TORONTO, May 08, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products is pleased to announce that all of management’s nominees listed in the Company’s management information circular dated April 2, 2026 (“Circular”) were elected as directors of the Company at its Annual General and Special Meeting of ShareholdersAvicanna Announces Change in Board of Directors
TORONTO, May 01, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products is announces that Eileen McCormack, who was not on the slate of directors for re-election or election as outlined in the circular at the upcoming annual general and special meeting of shareholders scheduled for Thursday May 7, 2026, has tendAvicanna Welcomes Initial U.S. Rescheduling of Medical Cannabis & Provides Scientific Update
Rescheduling aligns with Avicanna’s established pharmaceutical and medical cannabis strategy Rescheduling further supports advancement of R&D, clinical development, and medical affairs initiatives
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Avicanna
Sign Up For FreeTo access detailed company insights
Avicanna is an innovative biopharmaceutical company specializing in the development and commercialization of cannabinoid-based products for the medical and pharmaceutical markets. With a robust scientific platform, the company has successfully launched over thirty proprietary, evidence-based products and operates four commercial business pillars. A... Read More
